Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Aug 19;11(1):16821.
doi: 10.1038/s41598-021-96256-0.

Genetics of PlGF plasma levels highlights a role of its receptors and supports the link between angiogenesis and immunity

Affiliations

Genetics of PlGF plasma levels highlights a role of its receptors and supports the link between angiogenesis and immunity

Daniela Ruggiero et al. Sci Rep. .

Abstract

Placental growth factor (PlGF) is a member of the vascular endothelial growth factor family and is involved in bone marrow-derived cell activation, endothelial stimulation and pathological angiogenesis. High levels of PlGF have been observed in several pathological conditions especially in cancer, cardiovascular, autoimmune and inflammatory diseases. Little is known about the genetics of circulating PlGF levels. Indeed, although the heritability of circulating PlGF levels is around 40%, no studies have assessed the relation between PlGF plasma levels and genetic variants at a genome-wide level. In the current study, PlGF plasma levels were measured in a population-based sample of 2085 adult individuals from three isolated populations of South Italy. A GWAS was performed in a discovery cohort (N = 1600), followed by a de novo replication (N = 468) from the same populations. The meta-analysis of the discovery and replication samples revealed one signal significantly associated with PlGF circulating levels. This signal was mapped to the PlGF co-receptor coding gene NRP1, indicating its important role in modulating the PlGF plasma levels. Two additional signals, at the PlGF receptor coding gene FLT1 and RAPGEF5 gene, were identified at a suggestive level. Pathway and TWAS analyses highlighted genes known to be involved in angiogenesis and immune response, supporting the link between these processes and PlGF regulation. Overall, these data improve our understanding of the genetic variation underlying circulating PlGF levels. This in turn could lead to new preventive and therapeutic strategies for a wide variety of PlGF-related pathologies.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1
Figure 1
Manhattan plot of genome-wide association results in discovery analysis. Manhattan Plot showing − log10(p-values) for all SNPs of the PlGF discovery GWAS ordered by their chromosomal position. The blue dashed line indicates the suggestive association threshold (p-value < 1 × 10–6), while the red dashed line indicates the genome-wide significant threshold (p-value < 5 × 10–8). Blue dots are the SNPs associated at the suggestive significance level (p-value < 1 × 10–6). For each locus, the nearest gene is reported.

References

    1. Carmeliet P, et al. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat. Med. 2001 doi: 10.1038/87904. - DOI - PubMed
    1. Fischer C, Mazzone M, Jonckx B, Carmeliet P. FLT1 and its ligands VEGFB and PlGF: Drug targets for anti-angiogenic therapy? Nat. Rev. Cancer. 2008 doi: 10.1038/nrc2524. - DOI - PubMed
    1. Van de Veire S, et al. Further pharmacological and genetic evidence for the efficacy of PlGF inhibition in cancer and eye disease. Cell. 2010 doi: 10.1016/j.cell.2010.02.039. - DOI - PubMed
    1. Naik A, et al. Neuropilin-1 associated molecules in the blood distinguish poor prognosis breast cancer: A cross-sectional study. Sci. Rep. 2017 doi: 10.1038/s41598-017-03280-0. - DOI - PMC - PubMed
    1. Pagani E, et al. Placenta growth factor and neuropilin-1 collaborate in promoting melanoma aggressiveness. Int. J. Oncol. 2016 doi: 10.3892/ijo.2016.3362. - DOI - PubMed

Publication types

Substances